Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 0.77 |
| ▸ | CNR1 | P21554 | 8/20 | 0.77 |
| ▸ | FAAH | O00519 | 4/20 | 0.77 |
| ▸ | PPARG | P37231 | 2/20 | 0.74 |
| ▸ | PPARD | Q03181 | 2/20 | 0.74 |
| ▸ | PPARA | Q07869 | 2/20 | 0.74 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4919073 | 1.00 | CNR2 (0.77) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL26125952 | 0.98 | CNR2 (0.79) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL29498103 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL1872998 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL29483345 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL6055029 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL4312207 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL6055028 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL1030318 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD | |
| SCHEMBL1028869 | 0.95 | CNR2 (0.75) | CNR2CNR1FAAHPPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150079198-A1 | METHOD AND NUTRITIONAL SUPPLEMENT FOR ENHANCING WEIGHT GAIN OF A MAMMAL | SUPRAGENIX LLC | 2015-03-19 | — | — | US | claimed |
| US-9226906-B2 | Method and nutritional supplement for enhancing weight gain of a mammal | Supragenix, LLC (US) | 2016-01-05 | — | — | US | disclosed |
| US-9205121-B2 | Echinacea formulation | Integria Healthcare (Australia) PTY LTD (AU) | 2015-12-08 | — | — | US | disclosed |
| US-20150079198-A1 | METHOD AND NUTRITIONAL SUPPLEMENT FOR ENHANCING WEIGHT GAIN OF A MAMMAL | SUPRAGENIX LLC | 2015-03-19 | — | — | US | disclosed |
| US-20110059194-A1 | ECHINACEA FORMULATION | MEDIHERB HOLDINGS LTD. (AU) | 2011-03-10 | — | — | US | disclosed |
| US-20080124408-A1 | Echinacea Formulation | MEDIHERB HOLDINGS LTD. (AU) | 2008-05-29 | — | — | US | disclosed |
| WO-2006002493-A1 | AN ECHINACEA FORMULATION | MEDIHERB HOLDINGS LTD (AU) | 2006-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080124408-A1 | Echinacea Formulation | FAAH2, ABCC8, FAAH | CNR2 4/4885CNR1 18/4885FAAH 3/4885 |
| US-20110059194-A1 | ECHINACEA FORMULATION | FAAH2, ABCC8, FAAH | CNR2 4/4885CNR1 18/4885FAAH 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.